USD 631.2 million
Report ID:
SQMIG35A2188 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
91
|Figures:
76
Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 631.2 million in 2023 and is poised to grow from USD 674.75 million in 2024 to USD 1150.71 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
Helicobacter pylori H. pylori Diagnostics is becoming popular since It improves Diagnosis, Effective treatment, and reduces healthcare costs.
The early detection of H. pylori infections through diagnostic tests can be crucial in preventing the progression of these diseases and reducing the risk of complications. Diagnostic tests for H. pylori can accurately detect the presence of the bacteria in a patient's stomach or intestines. This early detection can help healthcare providers start appropriate treatment early, leading to better patient outcomes. With early treatment, patients can experience a reduction in symptoms and faster healing of ulcers. Moreover, early detection can also prevent the development of more severe complications, such as stomach cancer. The H. pylori diagnostic market offers a range of non-invasive diagnostic tests, such as blood tests, breath tests, and stool antigen tests, making them comfortable for patients and easily accessible. These tests are also cost-effective, allowing them to be available to a larger population.
The H. pylori market offers a wide range of treatment options, including antibiotics and acid-reducing medications, which are highly effective in treating infections caused by the Helicobacter pylori bacterium. Treating H. pylori infections can provide several benefits, such as relieving symptoms, preventing complications like ulcers and stomach cancer, and improving overall health. Effective treatment of H. pylori infections can prevent the development of peptic ulcers, a common complication associated with this bacterium. Peptic ulcers can cause abdominal pain, bloating, nausea, and vomiting, and can sometimes lead to more serious complications like bleeding and perforation of the stomach lining. By treating H. pylori infections, patients can reduce the risk of developing these complications and improve their overall quality of life.
US Helicobacter pylori H. pylori Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 631.2 million
Largest Segment
Hospitals
Fastest Growth
Hospital
Growth Rate
6.9% CAGR
To get more reports on the above market click here to Buy The Report
Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The segment of hospitals held the biggest market share due to several factors such as the easy manifestation of diseases, the accessibility of doctors, and the increasing prevalence of illnesses such as gastric ulcers, gastritis, stomach cancer, duodenal ulcers, and infections in the small intestine.
During the forecast period, the diagnostic laboratories segment is expected to exhibit the fastest Compound Annual Growth Rate (CAGR). This can be attributed to the increasing awareness of infectious diseases and the availability of more specialized and efficient infection detection methods. In terms of revenue, the hospitals and diagnostic laboratories segments collectively accounted for more than 80% of the market share in the projected period.
To get detailed analysis on other segments, Request For Free Sample Report
The Helicobacter pylori H. pylori Diagnostics market is mainly dominated by North America, due to factors such as high healthcare expenditure, favorable reimbursement policies, and a significant patient population. However, the Asia Pacific region is expected to emerge as the fastest-growing market in the near future, owing to various factors like the increasing prevalence of infections, growing healthcare infrastructure, and rising demand for advanced treatments. The large population base in the Asia Pacific region also presents a significant opportunity for market growth in the coming years.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
High Prevalence of H. pylori Infections is Boosting Market Growth
Limited Access to Health Care to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected employing Primary Exploratory Research backed by the robust Secondary Desk research.
After analyzing the global market for Helicobacter pylori H. pylori Diagnostics market, we anticipate a substantial expansion during the forecast period, attributed to its various benefits. These benefits encompass improved diagnosis, effective treatment, reduced healthcare costs, and a growing market. The high prevalence of H. pylori infections globally also drives the demand for H. pylori diagnostics and treatment.
Nonetheless, the market's growth may be hampered by the restricted access to healthcare facilities and diagnostic tools in developing countries.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 631.2 million |
Market size value in 2032 | USD 1150.71 million |
Growth Rate | 6.9% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Helicobacter pylori H. pylori Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Helicobacter pylori H. pylori Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Helicobacter pylori H. pylori Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Helicobacter pylori H. pylori Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 623 Million in 2023 and is poised to grow from USD 660.44 Million in 2024 to USD 1053.44 Million by 2032, growing at a CAGR of 6.01% during the forecast period (2025-2032).
The market for Helicobacter pylori (H. Pylori) products and services is highly competitive, as it involves the development and distribution of diagnostic tests and treatments for bacterial infection. There are several key players in the market, all striving to establish their dominance in the industry. One of the primary drivers of competition in the H. Pylori market is the growing prevalence of the infection worldwide. This trend has led to a significant increase in demand for effective diagnostic tests and treatments that can help combat the infection. As a result, companies are investing heavily in research and development to create innovative solutions that can improve patient outcomes and provide more accurate and effective results. Pricing strategies and marketing campaigns also play a crucial role in driving competition in the H. Pylori market. Companies are competing with each other by offering competitive pricing for their products, which helps to capture a larger market share and gain an advantage over their competitors. In addition, marketing campaigns are employed to raise awareness of their products and services, in order to attract more customers and increase sales. 'Abbott Laboratories', 'Allergan plc', 'AstraZeneca plc', 'Bayer AG', 'Bio-Rad Laboratories, Inc.', 'Danaher Corporation', 'F. Hoffmann-La Roche AG', 'GlaxoSmithKline plc', 'Halyard Health, Inc.', 'Hologic, Inc.', 'Merck & Co., Inc.', 'Mylan N.V.', 'Pfizer, Inc.', 'Quidel Corporation', 'Sanofi S.A.', 'Seegene Inc.', 'Siemens Healthineers AG', 'Thermo Fisher Scientific, Inc.', 'Trinity Biotech plc', 'ZEUS Scientific, Inc.'
The H. pylori market is fueled by the significant prevalence of H. pylori infections globally. Approximately half of the global population is estimated to be infected with H. pylori, making it one of the most commonly occurring bacterial infections. As a result, the demand for diagnostic tests and treatment options is on the rise. This is primarily due to the need for effective diagnosis and treatment of the infection.
The H. pylori infection market is witnessing an upward trend in demand for non-invasive diagnostic tests such as serology tests and urea breath tests. These tests are becoming increasingly popular due to their minimal invasiveness and easy-to-use nature, leading to an overall surge in their demand.
The Helicobacter pylori H. pylori Diagnostics market is mainly dominated by North America, due to factors such as high healthcare expenditure, favorable reimbursement policies, and a significant patient population. However, the Asia Pacific region is expected to emerge as the fastest-growing market in the near future, owing to various factors like the increasing prevalence of infections, growing healthcare infrastructure, and rising demand for advanced treatments. The large population base in the Asia Pacific region also presents a significant opportunity for market growth in the coming years.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2188
[email protected]
USA +1 351-333-4748